Clincosm LogoSign in Get a demo

Esophageal Adenocarcinoma

Showing 26 - 50 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Adenocarcinoma Trial in Buffalo (Carboplatin, 3 Dimensional Conformal Radiation Therapy, Propranolol)

Recruiting
  • Esophageal Adenocarcinoma
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 3, 2022

Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +3 more
  • New York, New York
  • +1 more
Jul 28, 2022

Barrett Esophagus, Esophageal Adenocarcinoma Trial in New York (Cytosponge)

Recruiting
  • Barrett Esophagus
  • Esophageal Adenocarcinoma
  • Cytosponge
  • New York, New York
    Columbia University Irving Medical Center
Jun 22, 2022

Esophageal Cancer, Esophageal Adenocarcinoma Trial in Amsterdam (Trastuzumab, Pertuzumab, Paclitaxel)

Recruiting
  • Esophageal Cancer
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
    Academic Medical Center
Jun 18, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Routine care as per site standard
  • Multiple Locations, Germany
    Multiple sites, Gemany
Jun 3, 2022

Esophageal Adenocarcinoma, Esophagus SCC, Cholangiocarcinoma Trial in Belgium, France (Abemaciclib)

Active, not recruiting
  • Esophageal Adenocarcinoma
  • +4 more
  • Antwerpen, Belgium
  • +10 more
May 27, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Kashiwa (Regorafenib,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
May 23, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
Has Results
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Esophageal Adenocarcinoma Trial in Mainz (Minimally invasive esophagectomy, daVinci Xi system)

Recruiting
  • Esophageal Adenocarcinoma
  • Minimally invasive esophagectomy
  • daVinci Xi system
  • Mainz, Germany
    University Medical Center Mainz
May 16, 2022

Nitrates and IL-8 in Barrett's Esophagus

Enrolling by invitation
  • Barrett Esophagus
  • Esophageal Adenocarcinoma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Mar 31, 2022

    Barrett Esophagus, Esophageal Adenocarcinoma, Reflux Disease Trial in Warsaw (Endoscopic radiofrequency ablation, Endoscopic

    Recruiting
    • Barrett Esophagus
    • +2 more
    • Endoscopic radiofrequency ablation
    • Endoscopic hybrid argon plasma coagulation
    • Warsaw, Poland
      Medical Centre for Postgraduate Education
    Feb 24, 2022

    Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

    Withdrawn
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • Duarte, California
    • +2 more
    Feb 21, 2022

    Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

    Recruiting
    • Melanoma
    • +7 more
    • Nivolumab or Pembrolizumab (dependent upon approved indication)
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Feb 10, 2022

    Gastric Tumor, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Dresden, Heidelberg (Biopsy)

    Active, not recruiting
    • Gastric Neoplasm
    • +4 more
    • Biopsy
    • Dresden, Germany
    • +1 more
    Feb 22, 2022

    Esophageal Adenocarcinoma, Barrett Esophagus, Colorectal Adenoma Trial in Groningen (SENSITIVE system)

    Not yet recruiting
    • Esophageal Adenocarcinoma
    • +6 more
    • SENSITIVE system
    • Groningen, Netherlands
      University Medical Center Groningen
    Feb 9, 2022

    Esophageal Adenocarcinoma Trial in Cologne, München (Durvalumab 50 MG/ML, Tremelimumab)

    Recruiting
    • Esophageal Adenocarcinoma
    • Cologne, Germany
    • +1 more
    Feb 17, 2022

    Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

    Recruiting
    • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
    • +18 more
    • Duarte, California
      City of Hope Medical Center
    Feb 16, 2022

    Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

    Recruiting
    • Gastric Adenocarcinoma
    • Esophageal Adenocarcinoma
    • Amsterdam, Netherlands
    • +7 more
    Jan 31, 2022

    Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

    Recruiting
    • Solid Tumor
    • +15 more
    • RAPA-201 Rapamycin Resistant T Cells
    • Chemotherapy Prior to RAPA-201 Therapy
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Dec 23, 2021

    Esophageal Adenocarcinoma Trial in United States (MatriStem PSM)

    Active, not recruiting
    • Esophageal Adenocarcinoma
    • MatriStem PSM
    • Basking Ridge, New Jersey
    • +3 more
    Sep 30, 2021

    Barrett's Esophagus, Esophageal Adenocarcinoma Trial in Baltimore (confocal laser endomicroscopy (CLE), standard endoscopy

    Completed
    Has Results
    • Barrett's Esophagus
    • Esophageal Adenocarcinoma
    • confocal laser endomicroscopy (CLE)
    • standard endoscopy (EGD)
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Jun 17, 2021

    Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Chicago (Pembrolizumab

    Recruiting
    • Gastroesophageal Junction Adenocarcinoma
    • +2 more
    • Pembrolizumab Injection
    • Chicago, Illinois
      University Of Chicago Medicine Comprehensive Cancer Center
    Jun 7, 2021

    Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Metastasis Trial in United States (Oxaliplatin, Leucovorin, 5 fluorouracil)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • +3 more
    • Duarte, California
    • +6 more
    May 10, 2021

    Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

    Completed
    • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
    • +5 more
    • S-1 de-escalation
    • Chemotherapy by Investigator's choice
    • Heidelberg, Baden-Württemberg, Germany
      NCT-Med. Onkologie
    Mar 25, 2021